Page last updated: 2024-08-24

zanamivir and Pneumonia

zanamivir has been researched along with Pneumonia in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's9 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boikos, C; Doll, MK; Gore, G; Kraicer-Melamed, H; Quach, C; Winters, N1
Ishii, H; Ishimoto, H; Kadota, JI; Mukae, H; Nishida, C; Noguchi, S; Sakamoto, N; Umeki, K; Yamasaki, K; Yatera, K1
Betsuyaku, T; Ogawa, T; Ohgino, K; Omori, N; Sayama, K; Tanaka, K1
Cabral, E; Carratalá, J; Cordero, E; Cruzado, JM; Delgado, JF; Gavaldá, J; Gómez-Bravo, MÁ; López-Medrano, F; Marcos, MÁ; Pérez-Romero, P; Sabé, N1
Del Mar, CB; Doshi, P; Hama, R; Heneghan, CJ; Howick, J; Jefferson, T; Jones, MA; Mahtani, KR; Nunan, D; Onakpoya, I; Spencer, EA; Thompson, MJ1
Boikos, C; Caya, C; Delisle, G; Doll, MK; Dolph, M; Gore, G; Kraicer-Melamed, H; Quach, C; Winters, N1
Härter, G; Kern, P; Maier, L; Mertens, T; Schubert, A; Wöhrle, J; Zimmermann, O1
Aardema, H; Boucher, CA; de Jager, CM; Riezebos-Brilman, A; Tulleken, JE; van den Biggelaar, RJ; Wolters, BA1
Bellomo, R; Charles, PG; Gordon, CL; Grayson, ML; Hart, GK; Johnson, PD; Langan, K; Torresi, J1
Rosen, DS1
Gross, PA1
Vogel, GE1

Reviews

5 review(s) available for zanamivir and Pneumonia

ArticleYear
Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses.
    The Journal of antimicrobial chemotherapy, 2017, Nov-01, Volume: 72, Issue:11

    Topics: Antiviral Agents; Disease Outbreaks; Enzyme Inhibitors; Hospitalization; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pneumonia; Zanamivir

2017
Management of influenza infection in solid-organ transplant recipients: consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the
    Enfermedades infecciosas y microbiologia clinica, 2013, Volume: 31, Issue:8

    Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Child; Cross Infection; Diagnosis, Differential; Disease Management; Drug Resistance, Viral; HN Protein; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Inpatients; Kidney Diseases; Organ Transplantation; Oseltamivir; Outpatients; Pneumonia; Postoperative Complications; Superinfection; Zanamivir

2013
Neuraminidase inhibitors for preventing and treating influenza in adults and children.
    The Cochrane database of systematic reviews, 2014, 04-10, Issue:4

    Topics: Adult; Antiviral Agents; Child; Drug Evaluation; Enzyme Inhibitors; Europe; Health Status; Humans; Influenza, Human; Japan; Legislation, Drug; Neuraminidase; Oseltamivir; Pneumonia; Publication Bias; Randomized Controlled Trials as Topic; United Kingdom; United States; Zanamivir

2014
Safety and effectiveness of neuraminidase inhibitors in situations of pandemic and/or novel/variant influenza: a systematic review of the literature, 2009-15.
    The Journal of antimicrobial chemotherapy, 2017, 06-01, Volume: 72, Issue:6

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Disease Outbreaks; Enzyme Inhibitors; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Middle Aged; Neuraminidase; Observational Studies as Topic; Oseltamivir; Pandemics; Pneumonia; Young Adult; Zanamivir

2017
Vaccines for pneumonia and new antiviral therapies.
    The Medical clinics of North America, 2001, Volume: 85, Issue:6

    Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Centers for Medicare and Medicaid Services, U.S.; Child; Global Health; Guanidines; Health Priorities; Humans; Incidence; Influenza Vaccines; Joint Commission on Accreditation of Healthcare Organizations; Morbidity; Neuraminidase; Oseltamivir; Patient Selection; Pneumococcal Vaccines; Pneumonia; Primary Prevention; Pyrans; Rimantadine; Safety; Sialic Acids; United States; Vaccination; Zanamivir

2001

Other Studies

7 other study(ies) available for zanamivir and Pneumonia

ArticleYear
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases.
    Respiratory investigation, 2017, Volume: 55, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Clarithromycin; Cohort Studies; Comorbidity; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Neuraminidase; Oseltamivir; Phosphorous Acids; Pneumonia; Prospective Studies; Treatment Outcome; Zanamivir

2017
Drug-induced pneumonitis following the administration of laninamivir octanoate: The first two reported cases.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:12

    Topics: Administration, Inhalation; Adult; Antiviral Agents; Bronchoalveolar Lavage; Female; Glucocorticoids; Guanidines; Humans; Influenza A virus; Influenza, Human; Lung; Neuraminidase; Pneumonia; Pyrans; Respiration, Artificial; Sialic Acids; Tomography, X-Ray Computed; Treatment Outcome; Viral Proteins; Young Adult; Zanamivir

2019
Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, May-01, Volume: 50, Issue:9

    Topics: Adult; Antiviral Agents; Critical Illness; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Injections, Intravenous; Male; Middle Aged; Pneumonia; Respiratory Distress Syndrome; Treatment Outcome; Zanamivir

2010
[Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
    Nederlands tijdschrift voor geneeskunde, 2010, Volume: 154

    Topics: Antiviral Agents; Drug Resistance, Viral; Fatal Outcome; Humans; Immunocompromised Host; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Oseltamivir; Pneumonia; Zanamivir

2010
Pooled human immunoglobulin therapy in critically Ill patients with pandemic 2009 influenza A(H1N1) pneumonitis and immunoglobulin G2 subclass (IgG2) deficiency.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011, Feb-01, Volume: 52, Issue:3

    Topics: Adult; Antiviral Agents; Common Variable Immunodeficiency; Critical Illness; Female; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Pneumonia; Pregnancy; Salvage Therapy; Treatment Outcome; Zanamivir

2011
Flu-fighting options: decisions, decisions....
    Health news (Waltham, Mass.), 2000, Volume: 6, Issue:12

    Topics: Acetamides; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza, Human; Oseltamivir; Pneumonia; Pyrans; Rimantadine; Sialic Acids; Zanamivir

2000
[Pneumonia diagnosis in the practice on the test-bench: how much diagnosis is necessary?].
    Deutsche medizinische Wochenschrift (1946), 2002, Mar-15, Volume: 127, Issue:11

    Topics: Acetamides; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Diagnosis, Differential; Enzyme Inhibitors; Female; Guanidines; Humans; Influenza, Human; Male; Neuraminidase; Oseltamivir; Pneumonia; Pyrans; Research; Sialic Acids; Time Factors; Zanamivir

2002